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Tuesday, June 1, 2021
During this COVID-19 pandemic and other future events, the CDM has been
and will continue to be a source of reliable information, education and models
for mitigation, preparedness, response, and recovery. We hope this
informational document has helped provide you filtered and actionable
information. As the pace of new information and changes occur, we will
evaluate the current once per week to determine if this information should be
provided on a more frequent basis.

David Markenson, M.D., M.B.A.
Director
Center for Disaster Medicine

COVID-19 Statistics
Total Cases

Total Deaths

Total Vaccine
Doses Admin.

Total Tested

Worldwide

170,814,464

3,551,884

1,927,961,965

Not Available

United States

33,266,191

594,603

294,733,321

Not Available

New Jersey

1,016,332

26,212

9,083,396

14,434,966

New York

2,102,404

53,303

19,605,540

55,927,263

Connecticut

347,341

8,238

4,024,797

8,476,087

Information as of 6/1/21 at 1200 EDT. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Center for Disaster Medicine Updates
● On May 11, 2021, CDM conducted a Stop the Bleed training to various medical and public
safety agencies in the region in order to better prepare them for disasters
● Coordinating and overseeing COVID-19 screenings at NYMC campus
● Continue to partner with local organizations such as Westchester Department of
Emergency Services and Westchester Medical Center to ensure ongoing collaboration with
all public safety agencies.
● Coordinating volunteers to support local public health response to COVID-19.

● Conducting research and analysis of current events and COVID-19 response to identify
strengths and areas for improvement in other regions.
● Updating and developing new programs to provide enhanced education on public health
emergencies including pandemics.
● Exploring course development opportunities in infection prevention and control for
frontline responders in the hospital and in the field.
● Serving as a source of information for COVID-19 related concerns or questions regarding
public health, emergency medical service (EMS), public safety and healthcare response.
● Local networking and pandemic response analysis for New York’s tri-state area, using
first-person experiences to highlight current trends.

To view the Center for Disaster Medicine's newest webinar, please click here - The
COVID-19 Vaccine: What to Tell Your Patients

The White House
President Biden issued a press release discussing the investigation into the origins of COVID19. He has asked the Intelligence Community to redouble their efforts to collect and analyze
information that could bring us closer to a definitive conclusion, and to report back in 90 days.
https://www.whitehouse.gov/briefing-room/statements-releases/2021/05/26/statement-bypresident-joe-biden-on-the-investigation-into-the-origins-of-covid-19/
The official website of the White House will deliver updated information as the country grapples
with converging crises. This will include actions to control the COVID-19 pandemic, provide
economic relief, tackle climate change, and advance racial equity and civil rights, as well as
immediate actions to reform our immigration system and restore America’s standing in the world.
This website will provide all information in one central location
https://www.whitehouse.gov

Health and Human Services (HHS)
Thanks to the American Rescue Plan, the U.S. Department of Health and Human Services
(HHS), through the Health Resources and Services Administration (HRSA), announced the
availability of approximately $250 million to develop and support a community-based workforce
who will serve as trusted voices sharing information about vaccines, increase COVID-19 vaccine
confidence, and address any barriers to vaccination for individuals living in vulnerable and
medically underserved communities.
https://www.hhs.gov/about/news/2021/05/04/hhs-announces-250-million-from-american-rescueplan-to-develop-and-support-underserved-communities.html
U.S. Health and Human Service (HHS) Secretary Xavier Becerra and U.S. Housing and Urban
Development (HUD) Secretary Marcia L. Fudge announced a joint-agency effort to increase
access to COVID-19 prevention and treatment services, including testing and vaccinations,
among disproportionately affected communities, including among HUD-assisted households and
people experiencing homelessness. This program will leverage the Health Center COVID-19
health Vaccine Program which currently provides a direct supply of vaccines to nearly 800 health
centers across the country. HHS and HUD expect the effort will reach more than 6,000
multifamily housing properties, 6,700 homeless shelters, and approximately 7,500 public housing
properties across the country to respond to and stop the spread of COVID-19.
https://www.hhs.gov/about/news/2021/05/05/hhs-secretary-becerra-hud-secretary-fudgeannounce-joint-effort-increase-access-covid-19-vaccinations.html
Thanks to the American Rescue Plan, the U.S. Department of Health and Human Services
(HHS) is announcing the availability of nearly $1 billion to strengthen COVID-19 response efforts
and increase vaccinations in rural communities. As part of the Biden Administration's
commitment to expanding access to vaccines and ensuring equity in the COVID-19 response,
the Health Resources and Services Administration, a part of HHS, will increase the number of
vaccines sent to rural communities, expand testing and other COVID-19 prevention services,

and work to increase vaccine confidence by empowering trusted local voices with additional
funding for outreach efforts in underserved communities.
https://www.hhs.gov/about/news/2021/05/04/hhs-announces-nearly-1-billion-from-americanrescue-plan-for-rural-covid-19-response.html
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html

National Institutes of Health (NIH)
View the latest COVID-19 information from NIH
https://www.nih.gov/coronavirus

United States Food and Drug Administration (FDA)
The U.S. Food and Drug Administration has announced the following actions taken in its
ongoing response effort to the COVID-19 pandemic:
•

This past week, FDA released the Medical Countermeasures Initiative
(MCMi) Program Update report which showcases FDA's work each year to
prepare for all types of public health emergencies, including COVID-19. This
report, covering fiscal year 2020, includes a snapshot of FDA's COVID-19
response during the reporting period.

•

•

•

As part of the FDA’s effort to protect consumers, on May 27, the agency issued
a warning letter jointly with the Federal Trade Commission to Oclo
Nanotechnology for selling unapproved chlorine dioxide products with unproven
COVID-19 claims. FDA continues to warn consumers not to drink chlorine dioxide
products including “OCLO 3000.” Drinking any chlorine dioxide product can cause
nausea, vomiting, diarrhea and symptoms of severe dehydration. Consumers
concerned about COVID-19 should consult with their health care provider.
On May 27, 2021, the FDA issued an Update: FDA Recommends Transition from
Use of Non-NIOSH-Approved and Decontaminated Disposable Respirators Letter to Health Care Personnel and Facilities. The FDA is recommending health
care personnel and facilities transition away from crisis capacity conservation
strategies, such as using non-NIOSH-approved disposable respirators, including
imported respirators such as KN95s. This recommendation is a follow-up to the
April 9, 2021, letter in which the FDA recommended a transition away from
decontamination or bioburden-reduction systems for cleaning and disinfecting
disposable respirators which were being reused by health care personnel.
Testing updates:
o As of 5/28/21, 379 tests and sample collection devices are authorized by
the FDA under emergency use authorizations (EUAs). These include 274
molecular tests and sample collection devices, 80 antibody and other
immune response tests and 25 antigen tests. There are 51 molecular
authorizations and one antibody authorization that can be used with
home-collected samples. There is one molecular prescription at-home
test, two antigen prescription at-home tests, four antigen over-the-counter
(OTC) at-home tests and two molecular OTC at-home tests.
o The FDA has authorized nine antigen tests and four molecular tests for
serial screening programs. The FDA has also authorized 516 revisions to
EUA authorizations.

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-updatemay-28-2021
For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19

Centers for Disease Control and Prevention (CDC)
CDC has updated their COVID-19 vaccine administration and delivery data. You can read
more about this information at https://covid.cdc.gov/covid-data-tracker/#vaccinations
CDC provides updated information about the variants in the United States- The emerging
variants CDC is closely monitoring have mutations in the virus genome that alter the
characteristics and cause the virus to act differently in ways that are significant to public
health (e.g., causes more severe disease, spreads more easily between humans,
requires different treatments, changes the effectiveness of current vaccines). It’s
important to understand that genetic mutations are expected, and some variants can
spread and become predominant while others subside.

https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and
trends of COVID-19 in the United States- updated daily by 8 pm ET.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html

Center for Medicare and Medicaid Services (CMS)
View the latest information from CMS
https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page

Vaccines
In this section, vaccine-related information from various sources will be collected,
reviewed, and tabulated here. As of June 1, 2021, the FDA has granted Emergency Use
Authorization (EUA) to Pfizer BioNTech, Moderna and Janssen/Johnson & Johnson. Now
with three vaccines with EUA, the goal is to vaccinate a larger number of persons in the
coming months throughout the United States. As additional vaccines are granted EUA,
information for those vaccines will also be included.
CDC has just published research from the first four months of this year discussing
breakthrough infections status post vaccine receipt. COVID-19 vaccines are a critical tool
for controlling the ongoing global pandemic. The Food and Drug Administration (FDA) has
issued Emergency Use Authorizations for three COVID-19 vaccines for use in the United
States.* In large, randomized-controlled trials, each vaccine was found to be safe and
efficacious in preventing symptomatic, laboratory-confirmed COVID-19 (1–3). Despite the
high level of vaccine efficacy, a small percentage of fully vaccinated persons (i.e. received
all recommended doses of an FDA-authorized COVID-19 vaccine) will develop
symptomatic or asymptomatic infections with SARS-CoV-2, the virus that causes COVID19 (2–8). https://www.cdc.gov/mmwr/volumes/70/wr/mm7021e3.htm
CDC provides update regarding Possible Side Effects After Getting a COVID-19 Vaccine.OVID-19 vaccination will help protect you from getting COVID-19. You may have some
side effects, which are normal signs that your body is building protection. These side
effects may affect your ability to do daily activities, but they should go away in a few days.
Some people have no side effects.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html
CDC releases COVID-19 Vaccine Toolkit for Institutions of Higher Education (IHE),
Community Colleges, and Technical Schools. More people get vaccinated when they
have strong confidence in the vaccines within their communities. And more people
vaccinated leads to fewer COVID-19 illnesses, hospitalizations, and deaths. CDC has
designed a toolkit to help administrators and staff at institutions of higher education (IHE)
share clear, complete, and accurate messages about COVID-19 vaccines. These unified
messages can help build confidence among students and staff and encourage COVID-19
vaccination among students.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/toolkits/higher-education.html

CDC created this section regarding COVID-19 vaccinations in the United States CDC
provides overall US COVID-19 Vaccine, deliveries and administration, maps, charts, and
data updated daily by 8 PM. This section represents all vaccine partners including
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal
Emergency Management Agency and Health Resources and Services Administration
partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide
updated relevant information including side effects and safety data, clinical trials
demographic statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic statistics,
and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the
distribution of the vaccine including the number of doses received by the state, a
breakdown of first or second doses, and the number of persons vaccinated with the first
and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
For NYC DOHMH updated guidance regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with information
to schedule vaccination appointments.
https://vaccinefinder.nyc.gov/

Educational Institution Information
•

Higher Education
o Online exam proctoring company ProctorU announced earlier this week
that it will no longer send artificial intelligence-generated reports of
potential student misconduct to institutions without ProctorU staff
members first reviewing the footage -- a development raising more
questions than it answers about higher education’s use of the technology.
ProctorU, like many companies offering remote proctoring services,

o

•

o
K-12
o

o

employs AI technology to monitor student movement during tests and flag
activity that might indicate a student is cheating. Typical behavior that
may be flagged by the AI includes students getting up from their seats,
not looking consistently at their screens or talking out loud. Previously, as
part of its cheapest proctoring package, ProctorU sent AI-generated
incident reports to instructors without staff members reviewing them first.
The company offered this package on the condition that any AI-generated
reports would be reviewed by instructors. But that wasn’t happening, said
Jarrod Morgan, founder and chief strategy officer of ProctorU.
https://www.insidehighered.com/news/2021/05/28/are-colleges-checkingais-work-remote-exam-proctoring
Some institutions took the COVID-19 crisis as an “opportunity to
turbocharge the corporate model,” says a new report from the American
Association of University Professors. Without declaring financial
exigency, they laid off faculty members “as expeditiously as if colleges
and universities were businesses whose CEOs suddenly decided to stop
making widgets or shut down the steelworks.” This phenomenon isn’t
unfamiliar to the AAUP. The organization made similar observations
about certain New Orleans-area institutions following the disaster that
was Hurricane Katrina. So much so that the AAUP warned early on in the
pandemic that COVID-19 could erode shared governance, via
administrations flouting their own institutional policies.
https://www.insidehighered.com/news/2021/05/26/aaup-finds-majorerosion-shared-governance-during-covid-19
Though the digital divide was thrust into the spotlight by the COVID-19
pandemic, the issue has been a persistent and growing equity concern
dating back several presidential administrations. With an estimated 29
million U.S. households with school-age children still lacking reliable
broadband access, the divide is set to remain an issue even as the
pandemic subsides. How the investments of the past year are sustained
and capitalized upon, and where future investments are made, will impact
the nation's educational outcomes for years to come. Our Decoding the
Divide series highlights specific barriers and solutions to these
challenges. We've gathered all four parts here for you to read and share
with colleagues. https://www.k12dive.com/news/decoding-the-divide-thestruggle-to-make-21st-century-learning-equitable-f/600717/

Clinical Trials
To view the latest information on clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=

American Red Cross

https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recovered-covid19-patients.html

State Updates
New York
•

Governor Andrew M. Cuomo announced that the New York State Department of Labor
is issuing guidance to all employers that any necessary recovery period from the
COVID-19 vaccine is covered under the state's Paid Sick Leave Law. According to a
recent survey conducted by the Kaiser Family Foundation, among unvaccinated
Americans, 48 percent say they are concerned they "might need to miss work if the side
effects of the vaccine make them feel sick for a day or more." This group includes nearly
two-thirds, or 64 percent, of unvaccinated Hispanic adults and over half of Black adults,
or 55 percent. https://www.governor.ny.gov/news/governor-cuomo-announces-newguidance-reminding-employers-new-yorks-paid-sick-leave-law-covers

New York State Department of Health (DOH)
For a list of positive cases by county in New York State
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down
cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH
https://coronavirus.health.ny.gov/home

New Jersey
•

Governor Phil Murphy issued Executive Order No. 243, which rescinds the requirement
in Executive Order No. 107 that businesses and non-profits accommodate telework
arrangements for their workforce to the maximum extent practicable and reduce their onsite staff to the minimal number necessary for their operations. Employers bringing
employees back to the physical worksite must continue to follow all applicable portions
of Executive Order No. 192, including notifying employees of on-site exposure and
performing health screenings of employees entering the worksite. The Order further
permits employers in indoor worksites that are closed to the public to allow employees
who can verify that they are vaccinated the ability to forego wearing a mask and social
distancing. Employers retain the ability to issue more restrictive policies on masking and

•

social distancing. Employers shall not restrict individuals from wearing masks and shall
not penalize or retaliate against individuals who choose to wear a mask.
https://nj.gov/infobank/eo/056murphy/pdf/EO-243.pdf
Governor Murphy today released a report on New Jersey’s response to the opioid
overdose epidemic during the COVID-19 public health emergency in 2020. The report
details the overdose mitigation strategies implemented over the course of Governor
Murphy’s administration that contributed to the resiliency demonstrated during the
convergence the opioid crisis and the pandemic. Governor Murphy also announced a
new public data dashboard from the Office of the Chief State Medical Examiner that will
provide public health partners and law enforcement agencies with near real-time data
regarding suspected-drug related deaths, enhancing their ability to rapidly address
potential threats to the community. Given the augmented risk for overdoses during the
pandemic, New Jersey anticipated a substantial increase in annual drug-related deaths
last year. Compared to 2019, New Jersey saw a slight increase in drug-related deaths,
but did not see the anticipated dramatic surge of deaths due to the COVID-19 pandemic
experienced in many states across the country. New Jersey lost 3,046 lives to
suspected drug-related deaths in 2020, compared to 3,021 suspected drug-related
deaths in 2019. The 2019 cases have now been confirmed, the Governor announced, to
be 2,914 lives lost to drug-related
deaths. https://nj.gov/governor/news/news/562021/approved/20210527a.shtml

Local Updates
New York Blood Center (NYBC)
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/

New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
For the latest COVID-19 information from NYC DOHMH
https://www1.nyc.gov/site/doh/covid/covid-19-main.page

Westchester County Department of Health
For the latest breakdown of positive cases in Westchester County as of May 23, 2021
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d
For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams
offering earlier access to vaccines.
https://health.westchestergov.com/2019-novel-coronavirus

Putnam County Department of Health
Breakdown of positive cases by towns in Putnam County as of May 21, 2021https://www.putnamcountyny.com/covid19/
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/

Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of May 24, 2021
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm

Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of May 24, 2021
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information

Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of
May 28, 2021
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/

Healthcare
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital
Association that covers hospitals in the tri-state area.
https://www.gnyha.org/

Center for Disaster Medicine Media
New York Medical College Leadership News:
Westchester High School Students Warming to COVID Vaccine Despite Concerns
https://www.theexaminernews.com/westchester-high-school-students-warming-to-covidvaccine-despite-concerns/
The Examiner News
5/27/21

Mill Etienne, M.D. '02, M.P.H. FAAN, FAES, vice chancellor for diversity and inclusion,
associate dean of student affairs and associate professor of neurology and of medicine,
Faculty News:
Health Experts See COVID-Related Suicide 'Crisis' Among Young
https://patch.com/new-york/newrochelle/health-experts-see-covid-related-suicide-crisisamong-young
Patch
5/27/2021
Stephen Ferrando, M.D., Har Esh Professor and Chair of the Department of Psychiatry and
Behavioral Sciences

Every effort is made to provide accurate and complete information in this newsletter. However, New
York Medical College cannot guarantee that there will be no errors. NYMC makes no claims, promises or
guarantees about the accuracy, completeness, or adequacy of the contents of the newsletters or the
articles linked herein and further expressly disclaims liability for errors and omissions in the contents of
this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the
advice of your physician or other qualified health provider with any questions you may have regarding a
medical condition.
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